echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Sudden injection drug recall!

    Sudden injection drug recall!

    • Last Update: 2022-01-12
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    The compliance of preservation conditions restricts the circulation of medicines


    We know that medicines must have corresponding storage and transportation conditions.


    Picture source FDA

    On December 2, the FDA announced the recall notice of Sandoz's enoxaparin sodium injection


    Picture source FDA

    The intended use of Enoxaparin Sodium Injection is to prevent deep vein thrombosis.


    According to the results of the official website of the China Food and Drug Administration, the specification has not yet been launched in China


    Tuyuan Xinhua News Agency

    What’s strange is that, among several enoxaparin sodium injections that the author has inquired about, including SANOFI SYNTHELABO, Shenzhen Tiandao, and Nanjing Jianyou Biochemical products, all products are stored below 25℃, while Suzhou Erye Pharmaceutical’s products do not exceed 20℃.


    In the past recalls of injections, most of the problems occurred in the production process of enterprises, such as:

    Microparticles are found in daptomycin for injection;

    Precipitation in furosemide sodium chloride injection;

    Microparticles are found in lactated Lin Ge injection;

    Ketorolac tromethamine injection found particles;

    There is an undeclared preservative benzyl alcohol in heparin sodium products;

    The impurity of methylprednisolone sodium succinate injection exceeds the standard;

    Cross contamination of dexmedetomidine hydrochloride injection and lidocaine;

    The product packaging of tranexamic acid for injection and amiodarone hydrochloride is confused;

    Neostigmine methyl methyl sulfate prefilled injection is mislabeled, etc.


    The high molecular polymers in Ceftazidime for Injection and Glucose Injection exceed the standard


    These are all produced during the production process of the company, but the quality control process has not been found to lead to a recall, which belongs to the improper supervision of the company itself


    As a manufacturer, we require the temperature data on the road during cold chain transportation to be sent to the consignee and the consignor after the goods arrive


    It is not clear whether the challenge test for storage conditions during the research and development process includes these harsh temperatures, but this method of recalling when encountering risks is still worth emulating


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.